Children’s Hospital of Orange County (CHOC Children’s) in California has purchased a new RIVA fully-automated IV compounding system from Intelligent Hospital Systems (IH Systems) to increase safety and efficiency.
CHOC expects the RIVA system to improve its workflow for vial handling, dose order management and more.
The RIVA fully-automated IV compounding system prepares medications for syringes and IV bags in an aseptic environment.
Additionally, the system has updated environmental controls and monitoring capabilities to support the latest Current Good Manufacturing Practice requirements.
Through an HL7 interface, Intelligent Hospital Systems’ USP compliant RIVA can exchange patient-specific information with medical applications inside the hospital. It can process individual or batch doses in an ISO Class 5 environment.
RIVA provides walk-away capability, allowing for extended production runs with no staff intervention required.
According to IH Systems, RIVA is recognised for its ability to safely and accurately prepare precise compounds in very small quantities. Its patient-specific preparations are based on patient size or weight.
RIVA can also dispense low-volume, low-concentration syringe output and intermediary bags with its high accuracy and dose repeatability.
In addition, the system is designed to reduce the cost-per-dose of medications and provide an electronic audit trail that identifies and labels every dispensed dose.
CHOC Children’s director of pharmacy operations Dr Grace Magedman noted that the hospital was an early adopter of pharmacy automation technology.
"We constantly strive to offer the highest standard in patient care through cutting-edge technology. Our hospital remains committed to that initiative by assessing further measures to increase efficiency and productivity, and improve patients’ overall experience," Dr Magedman added.
CHOC Children’s regional healthcare network includes two hospitals in Orange and Mission Viejo, several primary and speciality care clinics and a paediatric residency programme.
It has four centers of excellence – the CHOC Children’s Heart, Neuroscience, Orthopaedic and Hyundai Cancer institutes – and is affiliated with the University of California, Irvine.